After a ten-month pause, Psychedelic Health returns — renewed in purpose and ready to stand with an industry that has faced some of its most challenging years. The post We’re Back! appeared first on Psychedelic Health.| Psychedelic Health
In recent years, the UK has seen a resurgence in interest and investment in psychedelic research, particularly focusing on substances like psilocybin and MDMA. The post Here’s Everything You Need To Know About The Government’s Response On Rescheduling Psychedelics For Clinical Research appeared first on Psychedelic Health.| Psychedelic Health
The past year featured some of Britain’s most significant landmarks in advancing access to psychedelic medicine. The post The Past Year For Psychedelics In The UK: Licensing Moves Forward, Industry Consolidates and Trials Advance appeared first on Psychedelic Health.| Psychedelic Health
A newly published academic review has revisited one of the most sensational — and disputed — theories in psychedelic history: that early Christianity emerged from fertility cults using psychoactive mushrooms. The post Did Psychedelics Influence Early Christianity? A New Review Examines the Evidence appeared first on Psychedelic Health.| Psychedelic Health
A trend towards the legalization of psychedelic substances for medical use continues across the English-speaking world. The post Maryland Psychedelics Task Force Advances Medical Legalization Amid Growing US Reform Movement appeared first on Psychedelic Health.| Psychedelic Health
For the first time, a government-funded UK trial will investigate psilocybin-assisted psychotherapy for targetting relapses associated with opioid addiction, aiming to bring an innovative new therapy to the NHS if successful. The post Landmark UK trial to investigate psilocybin for opioid addiction relapse appeared first on Psychedelic Health.| Psychedelic Health
The European Citizens’ Initiative for Psychedelic-Assisted Therapies – launching at the start of 2025 – is aiming to collect one million signatures to urge the European Commission (EC) to take action on psychedelic-assisted therapies. The post European Citizen Initiative in support of psychedelic therapies to launch in 2025 appeared first on Psychedelic Health.| Psychedelic Health
A six-month follow-up study of a Phase 2 clinical trial investigating psilocybin versus escitalopram for the treatment of major depressive disorder has shown positive results. The post Psilocybin versus escitalopram for depression shows positive results appeared first on Psychedelic Health.| Psychedelic Health
Shortwave Life Sciences has announced it has achieved a significant breakthrough in its ambitions to transform eating disorder care with positive pre-clinical results from its latest pharmacodynamics study, demonstrating the safety of its psilocybin-based drug combination for the treatment of anorexia nervosa. The post Shortwave Life Sciences psilocybin drug shows positive results in anorexia trial appeared first on Psychedelic Health.| Psychedelic Health
The UK’s first trade association for psychedelics – Psychedelic Industry UK (PsyIndyUK) – has launched today, 18 September, to represent the country’s growing psychedelic medicine sector. The post UK’s first trade association for psychedelics launches appeared first on Psychedelic Health.| Psychedelic Health